Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation

Clinical Cancer Research

Volumn 2, Issue 10, 1996, Pages 1665-1671

  Spitz, Francis R ^a   Nguyen, Dao ^b   Skibber, John M ^a   Meyn, Raymond E ^a   Cristiano, Richard J ^b   Roth, Jack A ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GROWTH INHIBITION; HISTOCHEMISTRY; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; RADIOSENSITIZATION; TUMOR CELL LINE;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL SURVIVAL; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; IN SITU NICK-END LABELING; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029856574     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991
2. Levine, A. J., Momand, J., and Finlay, C. A. The p53 tumour suppressor gene. Nature (Lond.), 351: 453-456, 1991.
3. Lu, X., and Lane, D. P. Differential induction of transcriptionally active p53 following UV or ionizing radiation, defects in chromosome instability syndromes. Cell, 75: 765-778, 1993
4. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51; 6304-6311, 1991.
5. Kastan, M. B., Canman, C. E., and Leonard, C. J. p53, cell cycle control and apoptosis: implications for cancer Cancer Metastasis Rev., 14: 3-15, 1995.
6. Kuerbitz, S., Plunkett, B., Walsh, W., and Kastan, M. Wild-type p53 is a cell cycle checkpoint determinant following radiation. Nature (Lond.), 89: 7491-7495, 1992.
7. Fan, S., El-Deiry, W. S., Bae, I., Freeman, J., Jondle, D., Bhatia, K., Fornace, A. J., Jr., Magrath, I., Kohn, K. W., and O'Connor, P. M. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res., 54: 5824-5830, 1994.
8. Lowe, S., Ruley, H., Jacks, T., and Housman, D. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
9. Lowe, S., Schmitt, E., Smith, S., Osborne, B., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993
10. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C , Hooper, M. L., and Wyllie, A. H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362: 849-852, 1993.
11. Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D E., and Jacks, T. p53 status and the efficacy of cancer therapy in vivo. Science (Washington DC), 266: 807-810, 1994.
12. Radford, I. R. p53 status, DNA double-strand break repair proficiency, and radiation response of mouse lymphoid and rnyeloid cell lines. Int. J. Radiat. Biol., 66: 557-560, 1994.
13. Lee, J. M., and Bernstein, A. p53 mutations increase resistance to ionizing radiation. Proc. Natl. Acad Sci. USA, 90: 5742-5746, 1993.
14. Yonish-Rouach, E., Resnitzky, D., Rotem, J., Sachs, L., Kimchi, A., and Oren, M. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature (Lond.), 352: 345-347, 1991.
15. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., and Costa, J. Induction of apoptosis by wild-type p53 in a human colon tumorderived cell line. Proc. Natl. Acad. Sci. USA, 89: 4495-4499, 1992.
16. Ramqvist, T., Magnusson, K. P., Wang, Y , Szekeley, L., and Klein, G. Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53 Oncogene, 8: 1495-1500, 1993.
17. Fujiwara, T., Grimm, E. A., Mukhopadhyay, T., Cai, D. W., Owen-Schaub, L. B., and Roth, J. A. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res., 53: 4129-4133, 1993.
18. Zhang, W., Fang, X., Mazur, W., French, B. A., Georges, R. N., and Roth, J. A. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther., 1: 5-13, 1994.
19. Liu, T. J., Zhang, W. W., Taylor, D. L., Roth, J. A., Goepfert, H., and Clayman, G. L. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res., 54: 3662-3667, 1994.
20. Yang, C., Cirielli, C., Capogrossi, M C., and Passaniti, A. Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatitis tumor cells. Cancer Res., 55: 4210-4213, 1995.
21. Fujiwara, T., Grimm, E. A., Mukhopadhyay, T., Zhang, W. W., Owen-Schaub, L. B., and Roth, J. A. Induction of chemosensitivity in human lung cancer cells in vivo by adenoviral-mediated transfer of the wild-type p53 gene. Cancer Res., 54: 2287-2291, 1994.
22. Rodrigues, N. R., Rowan, A., Smith, M. E. F., Kerr, I. B., Bodmer, W. F., Gannon, J. V., and Lane, D. P. p53 mutations in colorectal cancer. Proc. Natl. Acad. Sci. USA, 87: 7555-7559, 1990.
23. Zhang, W. W., Fang, X., Branch, C. D., Mazur, W., French, B. A., and Roth, J. A. Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis. Biotechniques, 15: 868-872, 1993.
24. Graham, F., and Previc, L. Manipulation of adenovirus vectors. In: E. J. Murray (ed.), Methods in Molecular Biology: Gene Transfer and Expression Protocols 7, pp. 205-225. Clifton, NJ: Humana Press, 1991.
25. Zhang, W. W., Alemany, R., Wang, J., Kock, P. E., Ordonez, N. G., and Roth, J. A. Safety evaluation of Ad5CMV-p53 in vitro and in vivo. Hum. Gene Ther., 6: 155-164, 1995
26. Gorczyca, W., Bruno, S., Darzynkiewicz, R J., Gong, J., and Darzynkiewicz, Z. DNA strand breaks occurring in apoptosis: their early detection by deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int. J. Oncol., 1: 639-648, 1992
27. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
28. Brachman, D. G., Becket, M., Graves, D., Haraf, D., Vokes, E., and Weichselbaum, R R. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cells lines. Cancer Res., 53: 3667-3669, 1993.
29. 1 checkpoint does not decrease cell survival following DNA damage. Cancer Res., 53: 4164-4168, 1993.